Revolution Medicines, Inc.
RVMD
$39.13
$0.010.03%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -20.45% | -44.13% | -35.54% | -70.35% | -185.87% |
| Total Depreciation and Amortization | 20.68% | 39.67% | 65.10% | 10.30% | 11.27% |
| Total Amortization of Deferred Charges | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Non-Cash Items | -35.90% | 48.47% | -13.78% | -101.75% | 196.30% |
| Change in Net Operating Assets | 98.62% | 478.72% | -122.28% | -1,500.98% | 255.51% |
| Cash from Operations | -14.70% | -29.77% | -90.95% | -157.34% | -95.12% |
| Capital Expenditure | 47.26% | -38.86% | -114.39% | -80.15% | 19.44% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -3.60% | -122.47% | 360.09% | -4,354.41% | -8,842.41% |
| Cash from Investing | -3.29% | -127.75% | 347.90% | -6,305.36% | -5,254.76% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 30,461.63% | 7,545.30% | -88.39% | -99.75% | -95.04% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -88.62% | -- | -- | -- | 2,001,885.71% |
| Cash from Financing | 4.10% | 7,545.30% | -88.39% | -99.75% | 1,534.16% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.25% | -237.01% | 72.37% | -253.39% | 2,030.45% |
